Literature DB >> 20615080

Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review).

Ryan B Huang1, Supriya Mocherla, Michael J Heslinga, Phapanin Charoenphol, Omolola Eniola-Adefeso.   

Abstract

Vascular-targeted drug delivery systems could provide more efficient and effective pharmaceutical interventions for treating a variety of diseases including cardiovascular, pulmonary, inflammatory, and malignant disorders. However, several factors must be taken into account when designing these systems. The diverse blood hemodynamics and rheology, and the natural clearance process that tend to decrease the circulation time of foreign particles all lessen the probability of successful carrier interaction with the vascular wall. An effective vascular-targeted drug delivery system must be able to navigate through the bloodstream while avoiding immune clearance, attach to the vascular wall, and release its therapeutic cargo at the intended location. This review will summarize and analyze current literature reporting on (1) nanocarrier fabrication methods and materials that allow for optimum therapeutic encapsulation, protection, and release; (2) localization and binding dynamics of nanocarriers as influenced by hemodynamics and blood rheology in medium-to-large vessels; (3) blood cells' responses to various types of nanocarrier compositions and its effects on particle circulation time; and (4) properties that affect nanocarrier internalization at the target site.

Entities:  

Mesh:

Year:  2010        PMID: 20615080     DOI: 10.3109/09687688.2010.499548

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  10 in total

Review 1.  Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems.

Authors:  Daniel J Sobczynski; Margaret B Fish; Catherine A Fromen; Mariana Carasco-Teja; Rhima M Coleman; Omolola Eniola-Adefeso
Journal:  Ther Deliv       Date:  2015-08-14

2.  Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.

Authors:  Hongtao Xu; James Paxton; Joanne Lim; Yan Li; Wenli Zhang; Linda Duxfield; Zimei Wu
Journal:  Pharm Res       Date:  2014-03-18       Impact factor: 4.200

Review 3.  Dynamic factors controlling targeting nanocarriers to vascular endothelium.

Authors:  Vladimir R Muzykantov; Ravi Radhakrishnan; David M Eckmann
Journal:  Curr Drug Metab       Date:  2012-01       Impact factor: 3.731

4.  Design of nanovectors for therapy and imaging of cardiovascular diseases.

Authors:  Omolola Eniola-Adefeso; Michael J Heslinga; Tyrone M Porter
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

5.  Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells.

Authors:  Hongtao Xu; James W Paxton; Zimei Wu
Journal:  Pharm Res       Date:  2016-03-10       Impact factor: 4.200

Review 6.  Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.

Authors:  Eun Ji Chung; Matthew Tirrell
Journal:  Adv Healthc Mater       Date:  2015-06-17       Impact factor: 9.933

7.  Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles.

Authors:  Maria-Argyro Karageorgou; Dimosthenis Stamopoulos
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

8.  Ultrasmall gold nanorods: synthesis and glycocalyx-related permeability in human endothelial cells.

Authors:  Ming J Cheng; Nandita N Bal; Priya Prabakaran; Rajiv Kumar; Thomas J Webster; Srinivas Sridhar; Eno E Ebong
Journal:  Int J Nanomedicine       Date:  2019-01-17

Review 9.  The Hemocompatibility of Nanoparticles: A Review of Cell-Nanoparticle Interactions and Hemostasis.

Authors:  Kara M de la Harpe; Pierre P D Kondiah; Yahya E Choonara; Thashree Marimuthu; Lisa C du Toit; Viness Pillay
Journal:  Cells       Date:  2019-10-07       Impact factor: 6.600

10.  Co-Delivery Using pH-Sensitive Liposomes to Pancreatic Cancer Cells: the Effects of Curcumin on Cellular Concentration and Pharmacokinetics of Gemcitabine.

Authors:  Hongtao Xu; Yan Li; James W Paxton; Zimei Wu
Journal:  Pharm Res       Date:  2021-06-29       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.